Invention Grant
US08808696B2 Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
有权
使用TACI-融合分子治疗和预防异常细胞增殖的方法
- Patent Title: Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules
- Patent Title (中): 使用TACI-融合分子治疗和预防异常细胞增殖的方法
-
Application No.: US11501999Application Date: 2006-08-09
-
Publication No.: US08808696B2Publication Date: 2014-08-19
- Inventor: Herve Broly , Arnaud Ythier , Eric Sievers
- Applicant: Herve Broly , Arnaud Ythier , Eric Sievers
- Applicant Address: CH Aubonne US WA Seattle
- Assignee: Ares Trading S.A.,Zymogenetics, Inc.
- Current Assignee: Ares Trading S.A.,Zymogenetics, Inc.
- Current Assignee Address: CH Aubonne US WA Seattle
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The present invention provides methods and compositions for treatment of hyperproliferative disorders and cancers, including multiple myeloma and Waldenström's macroglobulinemia, comprising administering to a patient in need of the treatment a TACI-Ig fusion molecule in amount sufficient to suppress proliferation-inducing functions of BlyS and APRIL.
Public/Granted literature
- US20070207156A1 Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules Public/Granted day:2007-09-06
Information query
